Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cartesian Therapeutics, Inc. (RNAC) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cartesian Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1453687.
Total stock buying since 2016: $137,175,628.
Total stock sales since 2016: $17,118,314.
Total stock option exercises since 2016: $4,272,061.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 259,905 | $3,284,375 | 36,362 | $610,056 | 16,500 | $53,820 |
| 2024 | 1,880,493 | $12,622,382 | 241,836 | $4,224,217 | 19,260,148 | $3,457,999 |
| 2023 | 0 | $0 | 3,637 | $3,854 | 0 | $0 |
| 2022 | 6,861,600 | $188,460 | 31,115 | $86,279 | 42,813 | $21,000 |
| 2021 | 8,784,142 | $28,518,601 | 86,610 | $332,063 | 91,312 | $66,020 |
| 2020 | 9,089,485 | $20,113,876 | 13,314 | $44,734 | 111,718 | $133,456 |
| 2019 | 5,336,665 | $8,009,617 | 14,272 | $21,807 | 89,864 | $104,735 |
| 2017 | 513,758 | $7,708,315 | 663,072 | $11,264,859 | 155,223 | $401,560 |
| 2016 | 4,052,143 | $56,730,002 | 29,567 | $530,445 | 22,280 | $33,471 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-04 | 149,075 | $1,547,325 | 0 | $0 | 7,500 | $24,750 |
| 2025-03 | 89,863 | $1,371,167 | 0 | $0 | 0 | $0 |
| 2025-01 | 20,967 | $365,883 | 36,362 | $610,056 | 9,000 | $29,070 |
| 2024-12 | 0 | $0 | 13,664 | $345,612 | 13,664 | $19,265 |
| 2024-11 | 431,940 | $7,397,961 | 228,172 | $3,878,605 | 242,172 | $561,888 |
| 2024-10 | 205,721 | $4,336,276 | 0 | $0 | 3,036,746 | $0 |
| 2024-09 | 0 | $0 | 0 | $0 | 4,719,000 | $0 |
| 2024-08 | 15,516 | $197,221 | 0 | $0 | 0 | $0 |
| 2024-04 | 0 | $0 | 0 | $0 | 9,278,123 | $0 |
| 2024-03 | 1,223,316 | $688,278 | 0 | $0 | 1,970,443 | $2,876,846 |
| 2024-02 | 3,200 | $2,094 | 0 | $0 | 0 | $0 |
| 2024-01 | 800 | $552 | 0 | $0 | 0 | $0 |
| 2023-09 | 0 | $0 | 3,637 | $3,854 | 0 | $0 |
| 2022-12 | 0 | $0 | 0 | $0 | 10,938 | $0 |
| 2022-09 | 0 | $0 | 7,460 | $13,282 | 10,937 | $0 |
| 2022-06 | 130,000 | $149,760 | 0 | $0 | 10,938 | $0 |
| 2022-05 | 50,000 | $38,700 | 0 | $0 | 0 | $0 |
| 2022-04 | 6,681,600 | $0 | 0 | $0 | 0 | $0 |
| 2022-01 | 0 | $0 | 23,655 | $72,997 | 10,000 | $21,000 |
| 2021-12 | 4,061,663 | $12,405,385 | 34,765 | $103,732 | 10,938 | $0 |
| 2021-10 | 0 | $0 | 26,733 | $117,356 | 0 | $0 |
| 2021-09 | 0 | $0 | 4,523 | $20,398 | 10,937 | $0 |
| 2021-08 | 9,000 | $36,000 | 0 | $0 | 0 | $0 |
| 2021-05 | 4,693,479 | $15,986,916 | 0 | $0 | 13,629 | $37,752 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-04-15 | English Emily (Chief Operations Officer) | Option Ex | 7,500 | 3.30 | 24,750 |
| 2025-04-11 | Springer Timothy A (Director) | Buy | 42,750 | 10.77 | 460,545 |
| 2025-04-10 | Springer Timothy A (Director) | Buy | 57,170 | 10.68 | 610,518 |
| 2025-04-09 | Springer Timothy A (Director) | Buy | 49,155 | 9.69 | 476,262 |
| 2025-03-20 | Springer Timothy A (Director) | Buy | 54,889 | 15.59 | 855,609 |
| 2025-03-19 | Springer Timothy A (Director) | Buy | 20,234 | 14.97 | 302,963 |
| 2025-03-18 | Springer Timothy A (Director) | Buy | 14,740 | 14.42 | 212,595 |
| 2025-01-14 | Springer Timothy A (Director) | Buy | 4,022 | 18.00 | 72,396 |
| 2025-01-13 | Springer Timothy A (Director) | Buy | 16,945 | 17.32 | 293,487 |
| 2025-01-10 | Jewell Christopher M (Chief Scientific Officer) | Option Ex | 9,000 | 3.23 | 29,070 |
| 2025-01-06 | English Emily (Chief Operations Officer) | Sale | 906 | 16.83 | 15,249 |
| 2025-01-06 | Kurtoglu Metin (Chief Technology Officer) | Sale | 2,458 | 16.83 | 41,373 |
| 2025-01-06 | Miljkovic Milos (Chief Medical Officer) | Sale | 948 | 16.83 | 15,956 |
| 2025-01-06 | Jewell Christopher M (Chief Scientific Officer) | Sale | 1,286 | 16.83 | 21,645 |
| 2025-01-06 | Davis Blaine (Chief Financial Officer) | Sale | 4,028 | 16.83 | 67,799 |
| 2025-01-06 | Brunn Carsten (President and CEO) | Sale | 8,708 | 16.83 | 146,573 |
| 2025-01-03 | English Emily (Chief Operations Officer) | Sale | 891 | 16.72 | 14,899 |
| 2025-01-03 | Kurtoglu Metin (Chief Technology Officer) | Sale | 2,417 | 16.72 | 40,417 |
| 2025-01-03 | Miljkovic Milos (Chief Medical Officer) | Sale | 932 | 16.72 | 15,584 |
| 2025-01-03 | Jewell Christopher M (Chief Scientific Officer) | Sale | 1,264 | 16.72 | 21,136 |
| 2025-01-03 | Davis Blaine (Chief Financial Officer) | Sale | 3,961 | 16.72 | 66,235 |
| 2025-01-03 | Brunn Carsten (President and CEO) | Sale | 8,563 | 16.72 | 143,190 |
| 2024-12-10 | Kurtoglu Metin (Chief Technology Officer) | Sale | 2,901 | 24.35 | 70,639 |
| 2024-12-10 | Kurtoglu Metin (Chief Technology Officer) | Option Ex | 2,901 | 1.41 | 4,090 |
| 2024-12-09 | Kurtoglu Metin (Chief Technology Officer) | Sale | 10,763 | 25.55 | 274,973 |
| 2024-12-09 | Kurtoglu Metin (Chief Technology Officer) | Option Ex | 10,763 | 1.41 | 15,175 |
| 2024-11-21 | Kurtoglu Metin (Chief Technology Officer) | Sale | 32,789 | 16.67 | 546,559 |
| 2024-11-21 | Kurtoglu Metin (Chief Technology Officer) | Option Ex | 32,789 | 1.41 | 46,232 |
| 2024-11-20 | Kurtoglu Metin (Chief Technology Officer) | Sale | 5,700 | 17.68 | 100,798 |
| 2024-11-20 | Kurtoglu Metin (Chief Technology Officer) | Option Ex | 5,700 | 1.41 | 8,036 |
| 2024-11-20 | Jewell Christopher M (Chief Scientific Officer) | Option Ex | 14,000 | 3.23 | 45,220 |
| 2024-11-19 | Kurtoglu Metin (Chief Technology Officer) | Sale | 200 | 19.50 | 3,900 |
| 2024-11-19 | Kurtoglu Metin (Chief Technology Officer) | Option Ex | 200 | 1.41 | 282 |
| 2024-11-18 | Kurtoglu Metin (Chief Technology Officer) | Sale | 34,400 | 18.39 | 632,444 |
| 2024-11-18 | Kurtoglu Metin (Chief Technology Officer) | Option Ex | 34,400 | 1.41 | 48,504 |
| 2024-11-18 | Springer Timothy A (Director) | Buy | 58,295 | 18.19 | 1,060,327 |
| 2024-11-15 | Kurtoglu Metin (Chief Technology Officer) | Sale | 22,068 | 17.20 | 379,503 |
| 2024-11-15 | Kurtoglu Metin (Chief Technology Officer) | Option Ex | 22,068 | 1.41 | 31,115 |
| 2024-11-15 | Miljkovic Milos (Chief Medical Officer) | Sale | 20,000 | 17.14 | 342,879 |
| 2024-11-15 | Miljkovic Milos (Chief Medical Officer) | Option Ex | 20,000 | 3.23 | 64,600 |
| 2024-11-15 | Jewell Christopher M (Chief Scientific Officer) | Sale | 16,065 | 17.06 | 274,101 |
| 2024-11-15 | Jewell Christopher M (Chief Scientific Officer) | Option Ex | 16,065 | 3.23 | 51,889 |
| 2024-11-15 | Springer Timothy A (Director) | Buy | 277,246 | 17.09 | 4,739,243 |
| 2024-11-14 | Kurtoglu Metin (Chief Technology Officer) | Sale | 25,900 | 16.70 | 432,452 |
| 2024-11-14 | Kurtoglu Metin (Chief Technology Officer) | Option Ex | 25,900 | 1.41 | 36,519 |
| 2024-11-14 | Miljkovic Milos (Chief Medical Officer) | Sale | 35,000 | 16.13 | 564,655 |
| 2024-11-14 | Miljkovic Milos (Chief Medical Officer) | Option Ex | 35,000 | 3.23 | 113,050 |
| 2024-11-14 | Jewell Christopher M (Chief Scientific Officer) | Sale | 36,050 | 16.68 | 601,314 |
| 2024-11-14 | Jewell Christopher M (Chief Scientific Officer) | Option Ex | 36,050 | 3.23 | 116,441 |
| 2024-11-14 | Springer Timothy A (Director) | Buy | 96,399 | 16.58 | 1,598,391 |
| 2024-10-11 | Seven One Eight Three Four Irrevocable Trust (10% Owner) | Option Ex | 1,518,373 | .00 | 0 |
| 2024-10-11 | Kalayoglu Murat (Director) | Option Ex | 1,518,373 | .00 | 0 |
| 2024-10-04 | Springer Timothy A (Director) | Buy | 80,301 | 22.80 | 1,830,943 |
| 2024-10-03 | Springer Timothy A (Director) | Buy | 119,906 | 20.09 | 2,409,511 |
| 2024-10-02 | Springer Timothy A (Director) | Buy | 5,514 | 17.38 | 95,822 |
| 2024-09-25 | Springer Timothy A (Director) | Option Ex | 4,719,000 | .00 | 0 |
| 2024-08-12 | Barabe Timothy C (Director) | Buy | 7,500 | 12.70 | 95,250 |
| 2024-08-12 | Springer Timothy A (Director) | Buy | 8,016 | 12.72 | 101,971 |
| 2024-04-08 | Singer Michael (Director) | Option Ex | 753,781 | .00 | 0 |
| 2024-04-08 | Kalayoglu Murat (Director) | Option Ex | 3,418,617 | .00 | 0 |
| 2024-04-08 | Springer Timothy A (Director) | Option Ex | 5,105,725 | .00 | 0 |
| 2024-03-26 | Springer Timothy A (Director) | Option Ex | 1,970,443 | 1.46 | 2,876,846 |
| 2024-03-18 | Springer Timothy A (Director) | Buy | 19,844 | .60 | 11,895 |
| 2024-03-15 | Springer Timothy A (Director) | Buy | 538,700 | .57 | 315,109 |
| 2024-03-14 | Springer Timothy A (Director) | Buy | 650,372 | .54 | 352,479 |
| 2024-03-13 | Springer Timothy A (Director) | Buy | 3,200 | .58 | 1,868 |
| 2024-03-12 | Springer Timothy A (Director) | Buy | 1,200 | .61 | 734 |
| 2024-03-11 | Springer Timothy A (Director) | Buy | 1,200 | .65 | 784 |
| 2024-03-08 | Springer Timothy A (Director) | Buy | 4,800 | .66 | 3,187 |
| 2024-02-07 | Springer Timothy A (Director) | Buy | 2,400 | .66 | 1,574 |
| 2024-02-06 | Springer Timothy A (Director) | Buy | 800 | .65 | 520 |
| 2024-01-17 | Springer Timothy A (Director) | Buy | 800 | .69 | 552 |
| 2023-09-25 | Brunn Carsten (President and CEO) | Sale | 2,932 | 1.06 | 3,107 |
| 2023-09-25 | Traber Peter G (Chief Medical Officer) | Sale | 705 | 1.06 | 747 |
| 2022-12-01 | Brunn Carsten (President and CEO) | Option Ex | 10,938 | .00 | 0 |
| 2022-09-28 | Brunn Carsten (President and CEO) | Sale | 2,692 | 1.66 | 4,471 |
| 2022-09-02 | Brunn Carsten (President and CEO) | Sale | 4,768 | 1.85 | 8,811 |
| 2022-09-01 | Brunn Carsten (President and CEO) | Option Ex | 10,937 | .00 | 0 |
| 2022-06-13 | Cox Carrie Smith | Buy | 130,000 | 1.15 | 149,760 |
| 2022-06-01 | Brunn Carsten (President and CEO) | Option Ex | 10,938 | .00 | 0 |
| 2022-05-09 | Barabe Timothy C | Buy | 50,000 | .77 | 38,700 |
| 2022-04-11 | Springer Timothy A | Buy | 6,681,600 | .00 | 0 |
| 2022-01-14 | Barabe Timothy C | Option Ex | 10,000 | 2.10 | 21,000 |
| 2022-01-05 | Brunn Carsten (President and CEO) | Sale | 13,597 | 3.09 | 41,960 |
| 2022-01-05 | Kishimoto Takashi Kei (Chief Scientific Officer) | Sale | 3,416 | 3.09 | 10,541 |
| 2022-01-05 | Johnston Lloyd P. (Chief Operations Officer) | Sale | 3,416 | 3.09 | 10,541 |
| 2022-01-05 | Traber Peter G (Chief Medical Officer) | Sale | 3,226 | 3.09 | 9,955 |
| 2021-12-15 | Springer Timothy A | Buy | 211,190 | 2.99 | 631,035 |
| 2021-12-13 | Springer Timothy A | Buy | 14,592 | 2.98 | 43,498 |
| 2021-12-10 | Brunn Carsten (President and CEO) | Sale | 17,196 | 2.99 | 51,364 |
| 2021-12-10 | Kishimoto Takashi Kei (Chief Scientific Officer) | Sale | 4,370 | 2.99 | 13,053 |
| 2021-12-10 | Johnston Lloyd P. (Chief Operations Officer) | Sale | 4,370 | 2.99 | 13,053 |
| 2021-12-10 | Traber Peter G (Chief Medical Officer) | Sale | 4,083 | 2.99 | 12,195 |
| 2021-12-10 | Springer Timothy A | Buy | 58,681 | 2.99 | 175,456 |
| 2021-12-09 | Springer Timothy A | Buy | 3,748,000 | 3.06 | 11,468,880 |
| 2021-12-03 | Cox Carrie Smith | Buy | 17,200 | 2.95 | 50,671 |
| 2021-12-02 | Tan Kevin (Chief Financial Officer) | Buy | 5,000 | 3.02 | 15,125 |
| 2021-12-02 | Brunn Carsten (President and CEO) | Sale | 4,746 | 2.96 | 14,067 |
| 2021-12-02 | Desilva Nishan M | Buy | 7,000 | 2.96 | 20,720 |
| 2021-12-01 | Brunn Carsten (President and CEO) | Option Ex | 10,938 | .00 | 0 |
| 2021-10-13 | Brunn Carsten (President and CEO) | Sale | 15,313 | 4.39 | 67,224 |
| 2021-10-13 | Kishimoto Takashi Kei (Chief Scientific Officer) | Sale | 3,892 | 4.39 | 17,085 |
| 2021-10-13 | Johnston Lloyd P. (Chief Operations Officer) | Sale | 3,892 | 4.39 | 17,085 |
| 2021-10-13 | Traber Peter G (Chief Medical Officer) | Sale | 3,636 | 4.39 | 15,962 |
| 2021-09-02 | Brunn Carsten (President and CEO) | Sale | 4,523 | 4.51 | 20,398 |
| 2021-09-01 | Brunn Carsten (President and CEO) | Option Ex | 10,937 | .00 | 0 |
| 2021-08-18 | Barabe Timothy C | Buy | 9,000 | 4.00 | 36,000 |
| 2021-05-26 | Traber Peter G (Chief Medical Officer) | Buy | 20,000 | 3.99 | 79,860 |
| 2021-05-26 | Springer Timothy A | Buy | 926,170 | 4.00 | 3,705,606 |
| 2021-05-25 | Springer Timothy A | Buy | 383,830 | 3.55 | 1,362,212 |
| 2021-05-24 | Springer Timothy A | Buy | 590,000 | 3.38 | 1,991,840 |
| 2021-05-21 | Springer Timothy A | Buy | 2,773,479 | 3.19 | 8,847,398 |
| 2021-05-07 | Kishimoto Takashi Kei (Chief Scientific Officer) | Option Ex | 13,629 | 2.77 | 37,752 |
| 2021-03-18 | Traber Peter G (Chief Medical Officer) | Buy | 10,000 | 4.50 | 45,000 |
| 2021-03-17 | Johnston Lloyd P. (COO and SVP, R&D) | Sale | 15,128 | 4.45 | 67,319 |
| 2021-03-17 | Traber Peter G (Chief Medical Officer) | Buy | 10,000 | 4.53 | 45,300 |
| 2021-03-02 | Brunn Carsten (President and CEO) | Sale | 5,461 | 4.26 | 23,258 |
| 2021-03-01 | Brunn Carsten (President and CEO) | Option Ex | 10,937 | .00 | 0 |
| 2021-02-11 | Johnston Lloyd P. (COO and SVP, R&D) | Option Ex | 44,871 | .63 | 28,268 |
| 2020-12-14 | Traber Peter G (Chief Medical Officer) | Buy | 40,000 | 3.24 | 129,440 |
| 2020-12-02 | Brunn Carsten (President and CEO) | Sale | 3,323 | 3.35 | 11,135 |
| 2020-12-01 | Brunn Carsten (President and CEO) | Option Ex | 10,938 | .00 | 0 |
| 2020-10-23 | Kishimoto Takashi Kei (Chief Scientific Officer) | Option Ex | 30,000 | 2.77 | 83,100 |
| 2020-10-23 | Springer Timothy A | Buy | 994,488 | 2.71 | 2,700,034 |
| 2020-10-22 | Springer Timothy A | Buy | 1,770,204 | 2.63 | 4,657,406 |
| 2020-10-21 | Springer Timothy A | Buy | 880,000 | 2.50 | 2,199,120 |
| 2020-10-20 | Springer Timothy A | Buy | 910,000 | 2.21 | 2,012,920 |
| 2020-10-19 | Springer Timothy A | Buy | 759,500 | 2.36 | 1,794,698 |
| 2020-10-16 | Springer Timothy A | Buy | 218,196 | 2.42 | 528,034 |
| 2020-10-09 | Springer Timothy A | Buy | 276,703 | 2.00 | 552,575 |
| 2020-10-08 | Springer Timothy A | Buy | 530,441 | 1.89 | 1,000,942 |
| 2020-10-07 | Springer Timothy A | Buy | 654,953 | 1.65 | 1,078,707 |
| 2020-10-06 | Barabe Timothy C | Buy | 50,000 | 1.68 | 84,000 |
| 2020-10-06 | Springer Timothy A | Buy | 2,000,000 | 1.68 | 3,366,000 |
| 2020-09-02 | Brunn Carsten (President and CEO) | Sale | 3,364 | 2.39 | 8,033 |
| 2020-09-01 | Brunn Carsten (President and CEO) | Option Ex | 10,937 | .00 | 0 |
| 2020-06-24 | Barabe Timothy C | Option Ex | 32,840 | 1.46 | 47,946 |
| 2020-06-02 | Brunn Carsten (President and CEO) | Sale | 3,253 | 3.86 | 12,556 |
| 2020-06-01 | Brunn Carsten (President and CEO) | Option Ex | 10,938 | .00 | 0 |
| 2020-03-17 | Barabe Timothy C | Buy | 5,000 | 2.00 | 10,000 |
| 2020-03-03 | Brunn Carsten (President and CEO) | Sale | 3,374 | 3.86 | 13,010 |
| 2020-03-01 | Brunn Carsten (President and CEO) | Option Ex | 10,937 | .00 | 0 |
| 2020-01-16 | Johnston Lloyd P. (COO and SVP, R&D) | Option Ex | 5,128 | .47 | 2,410 |
| 2019-12-02 | Brunn Carsten (President and CEO) | Sale | 14,272 | 1.53 | 21,807 |
| 2019-12-01 | Brunn Carsten (President and CEO) | Option Ex | 43,750 | .00 | 0 |
| 2019-08-14 | Springer Timothy A | Buy | 10,000 | 1.74 | 17,420 |
| 2019-08-13 | Barabe Timothy C | Buy | 10,000 | 1.72 | 17,200 |
| 2019-07-23 | Johnston Lloyd P. (COO and SVP, R&D) | Option Ex | 10,000 | .47 | 4,700 |
| 2019-01-25 | Farokhzad Omid | Buy | 83,333 | 1.50 | 124,999 |
| 2019-01-25 | Nashat Amir (Director) | Buy | 1,166,666 | 1.50 | 1,749,999 |
| 2019-01-25 | Springer Timothy A | Buy | 4,066,666 | 1.50 | 6,099,999 |
| 2019-01-07 | Kishimoto Takashi Kei (Chief Scientific Officer) | Option Ex | 36,114 | 2.77 | 100,035 |
| 2017-11-17 | Sands Earl (Chief Medical Officer) | Buy | 7,500 | 10.26 | 76,965 |
| 2017-11-14 | Abraham David (GC, CCO & Corporate Secretary) | Buy | 5,405 | 9.25 | 49,996 |
| 2017-11-14 | Springer Timothy A (Director) | Buy | 57,598 | 9.27 | 534,106 |
| 2017-11-13 | Cautreels Werner (President and CEO) | Buy | 20,000 | 9.31 | 186,260 |
| 2017-11-10 | Barabe Timothy C (Director) | Buy | 2,500 | 9.00 | 22,505 |
| 2017-11-10 | Springer Timothy A (Director) | Buy | 31,090 | 9.03 | 280,895 |
| 2017-11-09 | Barabe Timothy C (Director) | Buy | 2,500 | 9.73 | 24,335 |
| 2017-11-09 | Springer Timothy A (Director) | Buy | 27,000 | 9.54 | 257,715 |
| 2017-09-26 | Nashat Amir (Director) | Sale | 70,226 | 18.91 | 1,328,114 |
| 2017-09-25 | Nashat Amir (Director) | Sale | 37,175 | 18.99 | 705,878 |
| 2017-09-22 | Nashat Amir (Director) | Sale | 42,036 | 19.26 | 809,781 |
| 2017-09-21 | Nashat Amir (Director) | Sale | 104,577 | 19.86 | 2,076,794 |
| 2017-09-20 | Siewers David (CFO and Treasurer) | Sale | 16,424 | 20.00 | 328,480 |
| 2017-09-20 | Siewers David (CFO and Treasurer) | Option Ex | 16,424 | .63 | 10,347 |
| 2017-09-20 | Nashat Amir (Director) | Sale | 42,610 | 20.03 | 853,393 |
| 2017-07-03 | Johnston Lloyd P. (COO and SVP, R*D) | Sale | 5,959 | 19.41 | 115,688 |
| 2017-07-03 | Johnston Lloyd P. (COO and SVP, R*D) | Option Ex | 5,959 | 2.77 | 16,506 |
| 2017-06-30 | Siewers David (Chief Financial Officer) | Sale | 7,420 | 20.00 | 148,407 |
| 2017-06-30 | Siewers David (Chief Financial Officer) | Option Ex | 7,420 | .63 | 4,674 |
| 2017-06-29 | Siewers David (Chief Financial Officer) | Sale | 9,652 | 20.00 | 193,040 |
| 2017-06-29 | Siewers David (Chief Financial Officer) | Option Ex | 9,616 | .55 | 5,288 |
| 2017-06-27 | Keller Peter (Chief Business Officer) | Sale | 4,595 | 19.30 | 88,683 |
| 2017-06-27 | Keller Peter (Chief Business Officer) | Option Ex | 4,595 | .63 | 2,894 |
| 2017-06-27 | Springer Timothy A (Director) | Buy | 338,791 | 17.71 | 5,999,988 |
| 2017-06-26 | Siewers David (Chief Financial Officer) | Sale | 6,886 | 20.00 | 137,720 |
| 2017-06-15 | Johnston Lloyd P. (COO and SVP, R*D) | Sale | 20,512 | 17.00 | 348,642 |
| 2017-06-15 | Johnston Lloyd P. (COO and SVP, R*D) | Option Ex | 20,512 | .47 | 9,640 |
| 2017-06-01 | Springer Timothy A (Director) | Buy | 518 | 13.75 | 7,122 |
| 2017-05-18 | Springer Timothy A | Buy | 4,860 | 14.00 | 68,040 |
| 2017-05-17 | Springer Timothy A | Buy | 11,244 | 14.01 | 157,483 |
| 2017-05-16 | Kania Edwin M Jr (Director) | Sale | 266,795 | 14.00 | 3,735,130 |
| 2017-04-17 | Johnston Lloyd P. (COO AND SVP, R&D) | Sale | 13,205 | 13.95 | 184,209 |
| 2017-04-17 | Johnston Lloyd P. (COO AND SVP, R&D) | Option Ex | 13,205 | .39 | 5,149 |
| 2017-03-27 | Barabe Timothy C (Director) | Option Ex | 2,492 | 11.00 | 27,412 |
| 2017-03-23 | Farokhzad Omid (Director) | Option Ex | 60,000 | 5.23 | 313,800 |
| 2017-01-23 | Johnston Lloyd P. (COO AND SVP, R&D) | Sale | 15,000 | 14.06 | 210,900 |
| 2017-01-23 | Johnston Lloyd P. (COO AND SVP, R&D) | Option Ex | 15,000 | .39 | 5,850 |
| 2016-12-28 | Kishimoto Takashi Kei (Chief Scientific Officer) | Sale | 10,000 | 17.55 | 175,500 |
| 2016-12-28 | Kishimoto Takashi Kei (Chief Scientific Officer) | Option Ex | 10,000 | 2.77 | 27,700 |
| 2016-12-21 | Abraham David (CCO, Gen.Counsel, Corp.Sec.) | Sale | 14,844 | 18.00 | 267,192 |
| 2016-12-21 | Abraham David (CCO, Gen.Counsel, Corp.Sec.) | Option Ex | 12,280 | .47 | 5,771 |
| 2016-12-19 | Keller Peter (Chief Business Officer) | Sale | 4,723 | 18.58 | 87,753 |
| 2016-06-27 | Osage Partners, Llc (10% Owner) | Buy | 350,000 | 14.00 | 4,900,000 |
| 2016-06-27 | Nanodimension Limited Partnership (10% Owner) | Buy | 385,000 | 14.00 | 5,390,000 |
| 2016-06-27 | Nashat Amir (Director) | Buy | 150,000 | 14.00 | 2,100,000 |
| 2016-06-27 | Rusnano (10% Owner) | Buy | 107,143 | 14.00 | 1,500,002 |
| 2016-06-27 | Polaris Venture Partners Special Founders' Fund V, L.p. (10% Owner) | Buy | 150,000 | 14.00 | 2,100,000 |
| 2016-06-27 | Gordon Carl L (Director) | Buy | 550,000 | 14.00 | 7,700,000 |
| 2016-06-27 | Isaly Samuel D (Director) | Buy | 1,100,000 | 14.00 | 15,400,000 |
| 2016-06-27 | Springer Timothy A (Director) | Buy | 710,000 | 14.00 | 9,940,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of RNAC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cartesian Therapeutics, Inc. (symbol RNAC, CIK number 1453687) see the Securities and Exchange Commission (SEC) website.